ADMA: ADMA Biologics, Inc. Company Profile & Statistics

About

ADMA Biologics, Inc. is a specialty immune globulin company. It develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases. The Company's target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. ADMA Biologics, Inc. is headquartered in Ramsey, New Jersey.

Info & Links

CEO

Adam S. Grossman

Headquarters

465 STATE ROUTE 17
RAMSEY, NJ 07446, UNITED STATES

Auditor

KPMG LLP

Share holders

Employees

685

ADMA Biologics, Inc. Statistics

Valuation Measures

Market Capitalization²

5.52B

Enterprise Value

5.50B

Enterprise Value/EBITDA(ttm)

37.21

Price to Earnings Ratio(ttm)

40.20

Price to Sales(ttm)

9.93

Price to Book(mrq)

16.39

Price to Cash(ytd)

316.42

Profitability

Gross Margin(ttm)

51.26%

Operating Margin(ttm)

24.64%

Profit Margin(ttm)

44.20%

Return on Equity(ttm)

53.20%

Return on Invested Capital(ttm)

52.34%

Return on Assets(ttm)

26.07%

Income Statement

Revenue(ttm)

426.45M

Revenue Per Share(ttm)

1.79

Gross Profit(ttm)

219.55M

EBITDA(ttm)³

147.84M

Net Income Available to Common(ttm)

197.67M

Diluted EPS(ttm)

0.28

Share Statistics

Beta (5Y Monthly)

0.75

52-Week Change

233.74%

S&P 500 52-Week Change

8.00%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

237.62M

Dividend Yield

0.00%

Float⁴

227.64M

% Held by Insiders

3.70%

% Held by Institutions

75.68%

Balance Sheet

Total Cash(mrq)

103.15M

Total Cash Per Share(mrq)

0.43

Total Debt(mrq)

82.12M

Total Debt/Equity(mrq)

23.53%

Current Ratio(mrq)

5.97%

Quick Ratio(mrq)

3.26%

Book Value Per Share(mrq)

1.48

Cash Flow

Operating Cash Flow Per Share(ytd)

0.49

Free Cash Flow(ytd)

110.45M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ADMA

ADMA Biologics, Inc.

ADMA Biologics, Inc. Profile